OCTAGAM-NOUA GENERAȚIE DE IMUNOGLOBULINA UMANA NORMALA DE UZ INTRAVENOS

March 1, 1998

Dr. Livia Baltag *
* Dr. Livia Baltag – Octapharma

Abstract

Octagam, developed by the Octapharma Laboratories, is a solution of lgG with a native molecular structure and physiologic lgG subclasses. The manufacturing procedure include several steps wich contribue to the inactivation, separation, and the neutralization of virus by high levels of antibody. The broad potential of intravenous immunoglobulin (IVIG) therapy for the treatment of immune­ mediated diseases is supported by incresing evidence on the immunomodulatory properties of normal immunoglobuli, noriginating from clinical trials.